Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer
Clinical trial NCT05250336 · UNKNOWN
Trial details
- NCT number
- NCT05250336
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-19
- Primary completion
- 2022-06-30
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.